Biotest
BIO.F
$44.11
Share price
0.49%
Change (1 day)
-6.84%
Change (1 year)
Categories
Operating Margin for Biotest (BIO.F)
Operating Margin as of May 2024 (TTM): -2.17%
According to Biotest 's latest financial reports and stock price the company's current Operating Margin is -2.17%. At the end of 2021 the company had an Operating Margin of -12.14%.
Operating Margin history for Biotest from 2009 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -12.14% | 95.96% |
| 2020 | -6.20% | 1897.43% |
| 2019 | -0.31% | -79.31% |
| 2018 | -1.50% | -78.2% |
| 2017 | -6.88% | -172.17% |
| 2016 | 9.53% | -175.61% |
| 2015 | -12.60% | -256.38% |
| 2014 | 8.06% | -15.57% |
| 2013 | 9.54% | 15.12% |
| 2012 | 8.29% | 22.43% |
| 2011 | 6.77% | -1.83% |
| 2010 | 6.90% | -37.99% |
| 2009 | 11.12% | 16.09% |
| 2008 | 9.58% | |
| 2004 | 2.86% | 338.03% |
| 2003 | 0.65% | -90.27% |
| 2002 | 6.70% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.